Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: J Subst Abuse Treat. 2020 Nov 23;122:108211. doi: 10.1016/j.jsat.2020.108211

Table 3:

Regression estimates of tobacco and alcohol outcomes for treatment (STAND) vs. control (TSP) at end-of-intervention 3 month follow up (N=148).

Effect estimate1 p-value
Tobacco Outcomes
 Verified abstinence (ITT: missing = smoking) .82 .803
 Self-reported abstinence (ITT: missing=smoking) 2.02 .118
 Self-reported abstinence (complete case) 2.16 .093
 Reduction in cigarettes smoked by 50% or more 1.11 .738
 Quit attempt during treatment 1.512 .270
 Preparation or higher stage of change 2.14 .025
 FTCD (B) −.302 .310
Alcohol Outcomes
 Days HED in past month (B) −.652 .535
 Drinks in past week (B) −2.233 .288
 Plans to limit drinking in next 30 days 1.04 .934
 AUDIT-C (B) −0.412 .247
Tobacco Alcohol Co-use Outcomes
 Est. % of smoking while drinking (B) −7.662 .156
 Prop. of past 30 days HED + tobacco (B) −.023 .405
 Combined use last drinking episode .51 .086
Other Outcomes
 E-cigarette/vaping in past 30 days .42 .010
 Cigarettes in past week (B) −14.79 .075

STAND (Smoking Tobacco and Drinking) intervention: Tobacco + Alcohol content; TSP (Tobacco Status Project) intervention: Tobacco only content

ITT (intent to treat) sample size: STAND N=85, TSP=94

FTCD: Fagerstrom Test of Cigarette Dependence, HED: heavy episodic drinking, AUDIT-C: Alcohol Use Disorder Identification Test – Concise

SD: standard deviation, IQR: interquartile range

1.

Effect estimates are odds ratios for dichotomous outcomes unless otherwise noted and B for continuous outcomes

2.

Estimate adjusts for baseline differences in intervention arms

3.

Adjusted for number of heavy episodic drinking days at baseline